ZIVO Bioscience (ZIVO) Competitors $20.96 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsTrends ZIVO vs. VYGR, ACRS, RZLT, CCCC, ITOS, IMMP, QURE, LYEL, LFCR, and MRSNShould you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Voyager Therapeutics (VYGR), Aclaris Therapeutics (ACRS), Rezolute (RZLT), C4 Therapeutics (CCCC), iTeos Therapeutics (ITOS), Immutep (IMMP), uniQure (QURE), Lyell Immunopharma (LYEL), Lifecore Biomedical (LFCR), and Mersana Therapeutics (MRSN). These companies are all part of the "pharmaceutical products" industry. ZIVO Bioscience vs. Voyager Therapeutics Aclaris Therapeutics Rezolute C4 Therapeutics iTeos Therapeutics Immutep uniQure Lyell Immunopharma Lifecore Biomedical Mersana Therapeutics ZIVO Bioscience (NASDAQ:ZIVO) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends. Do insiders and institutionals hold more shares of ZIVO or VYGR? 12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 21.5% of ZIVO Bioscience shares are held by insiders. Comparatively, 4.5% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, ZIVO or VYGR? Voyager Therapeutics has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$30K2,480.27-$7.78M-$4.88-4.30Voyager Therapeutics$250.01M1.18$132.33M$0.717.63 Do analysts rate ZIVO or VYGR? Voyager Therapeutics has a consensus target price of $17.00, suggesting a potential upside of 213.65%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Voyager Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in ZIVO or VYGR? Voyager Therapeutics received 291 more outperform votes than ZIVO Bioscience when rated by MarketBeat users. Likewise, 67.59% of users gave Voyager Therapeutics an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote. CompanyUnderperformOutperformZIVO BioscienceOutperform Votes9960.74% Underperform Votes6439.26% Voyager TherapeuticsOutperform Votes39067.59% Underperform Votes18732.41% Is ZIVO or VYGR more profitable? Voyager Therapeutics has a net margin of 15.80% compared to ZIVO Bioscience's net margin of -11,068.75%. Voyager Therapeutics' return on equity of 8.33% beat ZIVO Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets ZIVO Bioscience-11,068.75% N/A -2,240.92% Voyager Therapeutics 15.80%8.33%6.15% Which has more risk & volatility, ZIVO or VYGR? ZIVO Bioscience has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Does the media refer more to ZIVO or VYGR? In the previous week, Voyager Therapeutics had 24 more articles in the media than ZIVO Bioscience. MarketBeat recorded 25 mentions for Voyager Therapeutics and 1 mentions for ZIVO Bioscience. Voyager Therapeutics' average media sentiment score of 0.31 beat ZIVO Bioscience's score of -3.00 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment ZIVO Bioscience Very Negative Voyager Therapeutics Neutral SummaryVoyager Therapeutics beats ZIVO Bioscience on 17 of the 19 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get ZIVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIVO vs. The Competition Export to ExcelMetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.41M$2.93B$5.07B$8.90BDividend YieldN/A1.91%4.99%4.07%P/E Ratio-4.3016.1687.8613.46Price / Sales2,480.27282.771,228.8287.66Price / CashN/A169.3839.5136.27Price / Book-35.534.436.946.30Net Income-$7.78M-$41.63M$119.12M$225.93M7 Day Performance-2.51%-4.73%-1.84%-1.32%1 Month Performance5.39%-6.53%-3.65%0.60%1 Year Performance1,722.61%25.63%31.64%26.23% ZIVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIVOZIVO BioscienceN/A$20.96flatN/A+1,668.8%$74.41M$30,000.00-4.3010Negative NewsVYGRVoyager Therapeutics4.6676 of 5 stars$5.42+1.1%$17.00+213.7%-21.6%$296.10M$250.01M7.55100Analyst UpgradeAnalyst RevisionGap UpACRSAclaris Therapeutics3.948 of 5 stars$4.14+4.5%$8.80+112.6%+321.2%$295.72M$31.25M0.0086Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap DownRZLTRezolute4.1532 of 5 stars$5.08+1.4%$24.13+374.9%+568.0%$294.34MN/A0.0040CCCCC4 Therapeutics2.652 of 5 stars$4.10+1.2%$10.00+143.9%+139.6%$289.42M$20.76M0.00150Analyst ForecastITOSiTeos Therapeutics3.4955 of 5 stars$7.85-0.6%$31.50+301.3%-23.0%$286.76M$12.60M0.0090IMMPImmutep1.3099 of 5 stars$1.94-1.0%$8.50+338.1%+4.8%$282.19M$5.14M0.002,021QUREuniQure3.0851 of 5 stars$5.70-2.1%$17.00+198.2%-18.2%$277.82M$15.84M-1.15500News CoverageNegative NewsLYELLyell Immunopharma0.4947 of 5 stars$0.99-3.5%$1.00+0.6%-46.9%$277.43M$130,000.00-1.30270LFCRLifecore Biomedical1.5431 of 5 stars$7.48+5.5%$8.00+7.0%+0.7%$275.49M$128.26M93.50690MRSNMersana Therapeutics4.3672 of 5 stars$2.22flat$6.00+170.3%+38.8%$274.24M$36.85M0.00150Analyst Revision Related Companies and Tools Related Companies VYGR Alternatives ACRS Alternatives RZLT Alternatives CCCC Alternatives ITOS Alternatives IMMP Alternatives QURE Alternatives LYEL Alternatives LFCR Alternatives MRSN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZIVO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
